DMC Pharmaceutical Joint Stock Company (DMC) has just released its Q1/2025 financial report. Accordingly, revenue reached VND 215 billion, an increase of 15% compared to the same period last year, due to increased demand for products and market expansion. Gross profit reached VND 70 billion, corresponding to a gross profit margin of 32%. However, selling and administrative expenses increased slightly, resulting in a net profit of VND 35 billion, a decrease of 5% compared to Q1/2024. In addition, DMC has implemented new marketing strategies and upgraded its production line to improve product quality. Overall, while DMC experienced revenue growth in Q1/2025, increasing costs affected the net profit, necessitating cost optimization strategies in the upcoming quarters.
Leave a Reply